EGFR and ovarian cancer: As shown in Fig. 5A and B and Fig. S1, fentanyl treatment resulted in significantly increased phosphorylation of EGFR by 3.4-fold but not placental derived growth factor receptor (PDGFR), demonstrating the specific activation of EGFR by fentanyl in ovarian cancer cells.